SA Schroders VCP Global Allocation Portfolio OCSE:NOVO B Holdings History
SA Schroders VCP Global Allocation Portfolio's Novo Nordisk AS Holding Summary
As of 2025-04-30, SUNAMERICA SERIES TRUST held 5,436.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr358,960.00. This investment constitutes 0.17% of their stock portfolio, and SUNAMERICA SERIES TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q4. And since then SA Schroders VCP Global Allocation Portfolio has made 6 purchases of OCSE:NOVO B, at an average price of kr283.89, for a total of 63,792.00 shares. In addition, there have been 14 sales at an average price of kr373.10 for 58,356.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, SA Schroders VCP Global Allocation Portfolio's estimated gain on his OCSE:NOVO B holdings is kr5.92 Mil, reflecting a 32.67% gain to date.
SA Schroders VCP Global Allocation Portfolio OCSE:NOVO B (kr414.60) Holding Chart
SA Schroders VCP Global Allocation Portfolio OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
